Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptors (TCRs) recognizing Hevea brasiliensis latex peptides presented on HLA class II molecules are the primary mediators of the adaptive immune response in natural rubber latex (NRL) allergy (Sutherland et al., 2000). These receptors, typically found on CD4+ T helper cells, specifically recognize processed peptide fragments from major latex allergens such as Hev b 1, Hev b 3, Hev b 5, and Hev b 6.02 when they are displayed by Human Leukocyte Antigen (HLA) class II molecules, particularly HLA-DR and HLA-DQ (Rihs et al., 2002). Upon recognition, these TCRs trigger a signaling cascade that leads to the activation and expansion of Th2-polarized T cells, which secrete pro-inflammatory cytokines like IL-4, IL-5, and IL-13 (Sutherland et al., 2000). This cytokine environment promotes B-cell class switching to IgE, leading to sensitization and subsequent Type I hypersensitivity reactions, ranging from contact urticaria to life-threatening anaphylaxis (ThermoFisher, 2024). In the context of therapeutic development, these TCRs and their corresponding peptide-HLA complexes are targets for allergen-specific immunotherapy (AIT) and peptide-based vaccines aimed at inducing immune tolerance (Escobar et al., 2014). By modulating the activity of these TCR-bearing cells—such as through the induction of regulatory T cells (Tregs) or T-cell anergy—clinicians aim to reduce the allergic response to natural rubber latex (Escobar et al., 2014).
Induction of immune tolerance through T-cell anergy, immune deviation from Th2 to Th1/Treg profiles, and the expansion of allergen-specific regulatory T cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing Hevea brasiliensis latex peptides.